[Elsevier] Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, control... |
|
This post will be closed automatically in 2026-06-30 18:59
Best Answer
The day before yesterday 19:02
|
| |
50
[Full book]Recent Advances in Molecular Docking Methods, Tools, and Applications
10
Polymer and eco-friendly inhibitors for corrosion protection of reinforced concrete: A comprehensive review
10
Red wine clarification and stabilisation
10
Fundamentals of protein affinity chromatography: How to prepare and properly use an affinity matrix
10
Effects of alpha-lipoic acid supplementation on cardiometabolic risk factors: A systematic review and dose-response meta-analysis
